Stem Cell Isolation From Femoral Heads Post Total Hip Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDavid Hess

About this trial

Femoral heads will be collected at University Hospital (London, ON, Canada) from individuals with type-2 diabetes, obesity, and no T2D/no obesity controls. The femoral head will be taken to the Robarts Research Institute (London, ON, Canada) for lineage-restricted progenitor cell expansion and analyses. There the femoral heads will be used to isolate three stem cell types - Multipotent Stromal Cells, Endothelial Colony Forming Cells, and Hematopoietic Progenitor Cells. The yield and cell surface markers expressed on these cells will be measured using flow cytometry. These cell types will then undergo further analyses of the secretome, tubule forming assays, vascular regenerative cell exhaustion assays, and will be transplanted into immune deficient mice with with femoral artery ligation. These experiments are to assess the differences in function and expression of these cell types between individuals with type-2 diabetes and/or obesity and/or healthy controls.

Eligibility criteria

Qualifiers

Must be 18+ years of age

Disqualifiers

Diagnosis of bone cancers

Diagnosis of Rheumatoid arthritis

Diagnosis of hematopoietic conditions

Diagnosis of avascular necrosis of the hip

Trial design

Treatments tested in this trial

  • Hip Replacement

Treatment groups

30 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

David Hess

Lead sponsor

Western University, Canada

Sponsor institution